Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants
Abbott (NYSE: ABT) has reached agreements with three law firms to resolve the Gill case and claims involving approximately 2,000 other individuals relating to the company’s specialty formulas for preterm infants.